Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Exploratory review of placebo characteristics reported in randomised placebo controlled antidepressant drug trials.

Hughes J, Gabbay M, Funnell E, Dowrick C.

Pharmacopsychiatry. 2012 Jan;45(1):20-7. doi: 10.1055/s-0031-1286260. Epub 2011 Oct 6. Review.

PMID:
21979925
2.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2011 Apr;72(4):464-72. doi: 10.4088/JCP.10m06191. Erratum in: J Clin Psychiatry. 2011 Jun;72(6):874.

PMID:
21527123
3.

The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review.

Coverdale JH, McCullough LB, Chervenak FA.

Obstet Gynecol. 2008 Dec;112(6):1361-8. doi: 10.1097/AOG.0b013e31818c2a27. Review.

PMID:
19037048
4.

Signal detection and placebo response in schizophrenia: parallels with depression.

Mallinckrodt CH, Zhang L, Prucka WR, Millen BA.

Psychopharmacol Bull. 2010;43(1):53-72.

PMID:
20581800
5.

Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?

Khan A, Bhat A, Kolts R, Thase ME, Brown W.

CNS Neurosci Ther. 2010 Aug;16(4):217-26. doi: 10.1111/j.1755-5949.2010.00151.x. Epub 2010 Apr 16.

PMID:
20406269
6.

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.

Fountoulakis KN, Möller HJ.

J Psychopharmacol. 2012 May;26(5):744-50. doi: 10.1177/0269881111421969. Epub 2011 Sep 17.

PMID:
21926425
7.

The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials.

Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M.

J Affect Disord. 2012 Jan;136(1-2):e31-9. doi: 10.1016/j.jad.2011.06.022. Epub 2011 Jul 27. Review.

PMID:
21798601
8.

Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.

Dowrick CF, Hughes JG, Hiscock JJ, Wigglesworth M, Walley TJ.

BMC Health Serv Res. 2007 Apr 30;7:64.

9.

Systematic review of antidepressant therapies in Parkinson's disease.

Chung TH, Deane KH, Ghazi-Noori S, Rickards H, Clarke CE.

Parkinsonism Relat Disord. 2003 Dec;10(2):59-65. Review.

PMID:
14643994
11.

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.

Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI.

J Clin Psychiatry. 2010 Jun;71(6):682-8. doi: 10.4088/JCP.10r05976blu.

PMID:
20573327
12.

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.

J Clin Psychiatry. 2010 Mar;71(3):270-9. doi: 10.4088/JCP.08r04516blu. Epub 2010 Jan 26. Review.

PMID:
20122371
13.

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group..

CNS Drugs. 2008;22(7):587-602. Review.

PMID:
18547127
14.

Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.

Dworkin RH, Katz J, Gitlin MJ.

Neurology. 2005 Dec 29;65(12 Suppl 4):S7-19. Review.

PMID:
16385107
15.

The efficacy of antidepressants in the treatment of late-life depression.

Roose SP, Schatzberg AF.

J Clin Psychopharmacol. 2005 Aug;25(4 Suppl 1):S1-7. Review.

PMID:
16027554
16.

Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials.

Price A, Rayner L, Okon-Rocha E, Evans A, Valsraj K, Higginson IJ, Hotopf M.

J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):914-23. doi: 10.1136/jnnp.2010.230862. Epub 2011 May 10. Review.

PMID:
21558287
17.

Placebo response and antidepressant clinical trial outcome.

Khan A, Detke M, Khan SR, Mallinckrodt C.

J Nerv Ment Dis. 2003 Apr;191(4):211-8.

PMID:
12695731
18.
19.

Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?

Rihmer Z, Gonda X.

J Affect Disord. 2008 Jun;108(3):195-8. doi: 10.1016/j.jad.2008.01.020. Epub 2008 Feb 15.

PMID:
18280581
20.

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Papakostas GI, Fava M.

Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18823760

Supplemental Content

Support Center